---
schema_version: "secwatch.filing_event.v1"
accession: "0001650664-23-000005"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2023-10-10T23:59:59+00:00"
generated_at: "2026-06-10T02:29:05.894169+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine CTO and CBO Bruce Eaton to step down Jan 2, 2024

## Summary
- Bruce Eaton, EVP, Chief Technology Officer and Chief Business Officer, departs effective January 2, 2024.
- Severance includes 12 months base salary, COBRA contributions, and potential 2023 bonus.
- Stock option exercise extended to January 2, 2025; performance stock units may vest if metrics met by March 31, 2024.
- Separation agreement includes non-disparagement and confidentiality provisions; no successor named.

## SEC filing metadata
- accession: 0001650664-23-000005
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2023-10-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000165066423000005/0001650664-23-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000165066423000005/edit-20231003.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001650664-23-000005
- JSON: https://secwatch.observer/filing/0001650664-23-000005.json
- Plain text: https://secwatch.observer/filing/0001650664-23-000005.txt

## Key facts
- Executive change
  Bruce E. Eaton departed as Chief Technology Officer and Chief Business Officer at Editas Medicine, Inc..
  - Action: stepped down
  - Role: Chief Technology Officer and Chief Business Officer
  source text: Bruce E. Eaton, Ph.D., Executive Vice President, Chief Technology Officer and Chief Business Officer of the Company, agreed that Dr. Eaton will step down as Chief Technology Officer and Chief Business Officer effective January 2, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000165066423000005/0001650664-23-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.